Followers | 2459 |
Posts | 79989 |
Boards Moderated | 0 |
Alias Born | 06/15/2009 |
![](https://investorshub.advfn.com/uicon/157006.png?cb=1611901415)
Saturday, October 21, 2023 6:09:27 AM
Recent ICU News
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of SeaStar Medical Holding Corporation(ICU) Shareholders • PR Newswire (US) • 08/29/2024 09:45:00 AM
- Shareholders that lost money on SeaStar Medical Holding Corporation(ICU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 08/26/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/22/2024 09:45:00 AM
- Shareholders of SeaStar Medical Holding Corporation Should Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/19/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/15/2024 09:45:00 AM
- SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/13/2024 08:38:00 PM
- The Gross Law Firm Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 08/08/2024 09:45:00 AM
- Class Action Filed Against SeaStar Medical Holding Corporation (ICU) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 08/05/2024 09:45:00 AM
- Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
- First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s • GlobeNewswire Inc. • 07/17/2024 01:00:00 PM
- CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial • GlobeNewswire Inc. • 07/16/2024 12:30:00 PM
- Edelson Lechtzin LLP Urges SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action • PR Newswire (US) • 07/12/2024 09:05:00 PM
- SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner • GlobeNewswire Inc. • 07/12/2024 12:30:00 PM
- SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/11/2024 08:05:00 PM
- SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/10/2024 01:00:00 PM
- SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device • GlobeNewswire Inc. • 07/03/2024 12:30:00 PM
- SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology • GlobeNewswire Inc. • 06/11/2024 12:30:00 PM
- SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company • GlobeNewswire Inc. • 06/10/2024 12:30:00 PM
- Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation • GlobeNewswire Inc. • 06/07/2024 12:30:00 PM
- SeaStar Medical Announces 25-for-1 Reverse Stock Split • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility • GlobeNewswire Inc. • 05/22/2024 12:30:00 PM
- SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure • GlobeNewswire Inc. • 04/30/2024 12:30:00 PM
- SeaStar Medical Reports 2023 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 04/17/2024 08:00:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM